Faith A. Mutale, MSN, CRNPAbramson Cancer Center,
Hospital of the University of Pennsylvania,
December 4, 2020 | December 2020 Vol 11, No 12
The authors provide a brief background and an overview of cancer vaccine therapy, current research, clinical application, and current challenges.
October 6, 2020 | October 2020 Vol 11, No 10
For some patients, the use of CAR-T cell therapy has resulted in robust and durable (>95%) responses lasting longer than 5 years. Here’s what you need to know about CAR T-cell therapy.
September 9, 2020 | September 2020 Vol 11, No 9
Historically, surgery, chemotherapy, and radiation have been the mainstay of most cancer therapies. Although these modalities have been successful and improved survival outcomes, cancer remains one of the most debilitating diagnoses, often with poor outcomes.
Last modified: September 9, 2020